Old Web
English
Sign In
Acemap
>
authorDetail
>
Jonathan E Cohen
Jonathan E Cohen
Hadassah Medical Center
Cell biology
T cell
Chemistry
Immune checkpoint
Transcription factor
2
Papers
2
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
A phase 1a/1b trial of CSF-1R inhibitor LY3022855 in combination with durvalumab or tremelimumab in patients with advanced solid tumors.
2021
Investigational New Drugs
Gerald Steven Falchook
Marc Peeters
Sylvie Rottey
Luc Dirix
Radka Obermannová
Jonathan E Cohen
Ruth Perets
Ronnie Shapira-Frommer
Todd Michael Bauer
Judy Sing-Zan Wang
Richard D. Carvajal
Joshua Sabari
Sonya C. Chapman
Wei Zhang
Boris Calderon
Daniel A. Peterson
Show All
Source
Cite
Save
Citations (2)
Alternative splicing of SLAMF6 in human T cells creates a co-stimulatory isoform that counteracts the inhibitory effect of the full-length receptor
2020
bioRxiv
Emma Hajaj
Elad Zisman
Shay Tzaban
Sharon Merims
Jonathan E Cohen
Shiri Klein
Shoshana Frankenburg
Moshe Sade-Feldman
Yuval Tabach
Keren Yizhak
Ami Navon
Polina Stepensky
Nir Hacohen
Tamar Peretz
André Veillette
Rotem Karni
Galit Eisenberg
Michal Lotem
Show All
Source
Cite
Save
Citations (0)
1